MRNS - Marinus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRNS is currently covered by 9 analysts with an average price target of $11.66. This is a potential upside of $11.4 (4384.62%) from yesterday's end of day stock price of $0.26.

Marinus Pharmaceuticals's activity chart (see below) currently has 46 price targets and 72 ratings on display. The stock rating distribution of MRNS is 92.86% BUY and 7.14% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.6% with an average time for these price targets to be met of 44.43 days.

Highest price target for MRNS is $13, Lowest price target is $3, average price target is $11.66.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 24-Sep-2024.

Currently out of the existing stock ratings of MRNS, 39 are a BUY (92.86%), 3 are a HOLD (7.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$11.15 (602.70%)

$13

2 months 20 days ago
(24-Sep-2024)

0/7 (0%)

$11.1 (584.21%)

Hold

$6

$4.15 (224.32%)

$9

2 months 21 days ago
(23-Sep-2024)

1/6 (16.67%)

$4.31 (255.03%)

5

Buy

$13

4 months ago
(14-Aug-2024)

1/6 (16.67%)

$6.1 (88.41%)

309

Buy

$11

$9.15 (494.59%)

$11

4 months ago
(14-Aug-2024)

0/15 (0%)

$9.9 (900.00%)

Buy

$3

$1.15 (62.16%)

$21

7 months 29 days ago
(15-Apr-2024)

2/10 (20%)

$1.7 (130.77%)

247

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRNS (Marinus Pharmaceuticals) average time for price targets to be met?

On average it took 44.43 days on average for the stock forecasts to be realized with a an average price target met ratio 5.6

Which analyst has the current highest performing score on MRNS (Marinus Pharmaceuticals) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the most public recommendations on MRNS (Marinus Pharmaceuticals)?

Brian Abrahams works at RBC and has 21 price targets and 13 ratings on MRNS

Which analyst is the currently most bullish on MRNS (Marinus Pharmaceuticals)?

Marc Goodman with highest potential upside - $21.15

Which analyst is the currently most reserved on MRNS (Marinus Pharmaceuticals)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?